Investor Alert: Robbins LLP Informs Stockholders of the Cerevel Therapeutics Holdings, Inc. Class Action

SAN DIEGO, April 4, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed against Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company"), Bain Capital Investors, LLC ("Bain") and Pfizer, Inc. ("Pfizer") on behalf of a class (the "Class") consisting of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024, inclusive, and thus were damaged by defendants' violations of Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act"); (b) held shares of Cerevel as of January 8, 2024 (the "Record Date") and were entitled to vote on the merger of Cerevel and AbbVie Inc. ("AbbVie") and thus were damaged by defendants' violations of Section 14(a) of the Exchange Act; and/or (c) sold shares of Cerevel stock contemporaneously with Bain's purchase of shares on or about October 16, 2023 and thus were damaged by Bain's violations of Section 20A of the Exchange Act.

Read more at prnewswire.com